Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients1-Reference-Cited by-同舟云学术

Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients1

Published:2004-03-27 Issue:6 Volume:77 Page:890-897
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Bonaros Nikolaos E.,Kocher Alfred,Dunkler Daniela,Grimm Michael,Zuckermann Andreas,Ankersmit Jan,Ehrlich Marek,Wolner Ernst,Laufer Günther

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference30 articles.

1. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation;Rubin;JAMA,1989

2. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients;Sia;Clin Microb Rev,2000

3. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis;Grattan;JAMA,1989

4. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy;Everett;J Heart Lung Transplant,1992

5. Epidemiology of cytomegalovirus infections;Ho;Rev Infect Dis,1990

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dimensional mass cytometry identified circulating natural killer T-cell subsets associated with protection from cytomegalovirus infection in kidney transplant recipients;Kidney International;2024-04

2. Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management. A report from the CMV International Symposium 2023;Transplant Infectious Disease;2023-11-09

3. Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation;Immunity, Inflammation and Disease;2023-11

4. Diagnosis and treatment for the early stage of cytomegalovirus infection during hematopoietic stem cell transplantation;Frontiers in Immunology;2022-09-23

5. Recent progress in development of monoclonal antibodies against human cytomegalovirus;Current Opinion in Virology;2022-02